Neurosterix

Recent Finacing

Series A

Recent Raise

$63M

Neurosterix is a biopharmaceutical company developing allosteric modulators for neurological disorders, leveraging Addex's high-throughput allosteric drug discovery platform and advancing an M4 PAM program for schizophrenia.

Founded 2024

Geneve, Switzerland

11-50

Private

neurosterix.com

Highlights

Focus Areas

Biopharma

Medical

Recent Investors

Financials

$63M

Total Raised

1

Funding round

2

Investors

Team

Upgrade to view the team

See the team members at Neurosterix.